Neuropediatrics 2020; 51(02): 170-172
DOI: 10.1055/s-0039-3399528
Short Communication
Georg Thieme Verlag KG Stuttgart · New York

Unilateral Hearing Loss Due to Cochlear Nerve Involvement as Isolated Symptom of a Primary Medulloblastoma

1   Department of Neuropaediatrics, Developmental Neurology, Social Paediatrics, University Children's Hospital, Tübingen, Germany
,
Thomas Nägele
2   Department of Radiology, Section of Diagnostic and Interventional Neuroradiology, Tübingen, Germany
,
Michael Alber
1   Department of Neuropaediatrics, Developmental Neurology, Social Paediatrics, University Children's Hospital, Tübingen, Germany
,
Annette Weichselbaum
1   Department of Neuropaediatrics, Developmental Neurology, Social Paediatrics, University Children's Hospital, Tübingen, Germany
,
Martin Ebinger
3   General Paediatrics, Oncology/Haematology, University Children's Hospital, Tübingen, Germany
,
Martin U. Schuhmann
4   Department of Neurosurgery, Section of Pediatric Neurosurgery, Tübingen, Germany
› Author Affiliations
Further Information

Publication History

28 June 2019

07 September 2019

Publication Date:
07 November 2019 (online)

Abstract

Unilateral sensorineural hearing loss is a common symptom of vestibular schwannomas in adolescent patients with neurofibromatosis type 2 or sporadic vestibular schwannomas and is often the initial clinical feature. While rare cases of sensorineural impairment presenting as vision or hearing loss due to metastatic medulloblastoma are known, hearing loss as an isolated presenting symptom of primary malignant neuroepithelial tumors of the central nervous system has not been reported in the pediatric population so far. We present two adolescents with unilateral hearing loss due to cochlear nerve dysfunction as the only symptom of a primary nonmetastatic medulloblastoma of the WNT signaling pathway family members subgroup.

 
  • References

  • 1 Kenna MA. Acquired hearing loss in children. Otolaryngol Clin North Am 2015; 48 (06) 933-953
  • 2 Slattery WH. Neurofibromatosis type 2. Otolaryngol Clin North Am 2015; 48 (03) 443-460
  • 3 Wilne S, Collier J, Kennedy C, Koller K, Grundy R, Walker D. Presentation of childhood CNS tumours: a systematic review and meta-analysis. Lancet Oncol 2007; 8 (08) 685-695
  • 4 Wilne S, Collier J, Kennedy C. , et al. Progression from first symptom to diagnosis in childhood brain tumours. Eur J Pediatr 2012; 171 (01) 87-93
  • 5 Amene CS, Yeh-Nayre LA, Crawford JR. Isolated sensorineural hearing loss as initial presentation of recurrent medulloblastoma: neuroimaging and audiologic correlates. Clin Neuroradiol 2013; 23 (04) 301-303
  • 6 Garrity JA, Herman DC, Dinapoli RP, Waller RR, Campbell RJ. Isolated metastasis to optic nerve from medulloblastoma. Ophthalmology 1989; 96 (02) 207-210
  • 7 Wilne SH, Ferris RC, Nathwani A, Kennedy CR. The presenting features of brain tumours: a review of 200 cases. Arch Dis Child 2006; 91 (06) 502-506
  • 8 Perreault S, Ramaswamy V, Achrol AS. , et al. MRI surrogates for molecular subgroups of medulloblastoma. AJNR Am J Neuroradiol 2014; 35 (07) 1263-1269
  • 9 Skowron P, Ramaswamy V, Taylor MD. Genetic and molecular alterations across medulloblastoma subgroups. J Mol Med (Berl) 2015; 93 (10) 1075-1084
  • 10 Millard NE, De Braganca KC. Medulloblastoma. J Child Neurol 2016; 31 (12) 1341-1353 . Doi: 10.1177/0883073815600866 Correct ion in: J Child Neurol. 2016 Sep 15: 0883073816670445
  • 11 Wefers AK, Warmuth-Metz M, Pöschl J. , et al. Subgroup-specific localization of human medulloblastoma based on pre-operative MRI. Acta Neuropathol 2014; 127 (06) 931-933
  • 12 Brasme JF, Grill J, Doz F. , et al. Long time to diagnosis of medulloblastoma in children is not associated with decreased survival or with worse neurological outcome. PLoS One 2012; 7 (04) e33415